Catalyst
Slingshot members are tracking this event:
Anavex's (AVXL) 3-71 for Frontotemporal Dementia Granted Orphan Drug Designation by FDA
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AVXL |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 08, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
3-71, Frontotemporal Dementia, Fda, Orphan Drug Designation
